Rena Therapeutics is Biotechnology in Japan that focus on Hetero-Duplex oligonucleotides business. Founded in 2015. They cover business area such as developer, Hetero-Duplex, technology, nucleic acid medicine, biotech company, nucleic acid therapeutic research, its client, development, any nucleic acid therapeutic, pipeline.
2015
( 9 years old in 2024 )
Hetero-Duplex Oligonucleotides
-
1-9-2 Otemachi, Global Business Hub, Otemachi Financial City Grand Cube
3rd Floor
Tokyo, Chiyoda-ku 100-0004
Japan
Private
developerHetero-Duplextechnologynucleic acid medicinebiotech companynucleic acid therapeutic researchits clientdevelopmentany nucleic acid therapeuticpipeline
* We use standard office opening hours in near Rena Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Rena Therapeutics is Biotechnology business from Japan that founded in 2015 (9 years old in 2024), Rena Therapeutics business is focusing on Hetero-Duplex Oligonucleotides.
Rena Therapeutics headquarter office and corporate office address is located in 1-9-2 Otemachi, Global Business Hub, Otemachi Financial City Grand Cube 3rd Floor Tokyo, Chiyoda-ku 100-0004 Japan.
Rena Therapeutics was founded in Japan.
In 2024, Rena Therapeutics is currently focus on Hetero-Duplex oligonucleotides sector.
Above is snippet of Google Trends for "Hetero-Duplex oligonucleotides" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Rena Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
